Genomics4S

The global AI in clinical trials market, valued at US$1.20 billion in 2023, is projected to grow at a 12.4% annually, reaching US$2.74 billion by 2030. As AI reshapes how patients are identified, matched, and enrolled in clinical research, regulatory frameworks must evolve to address the structural diversity, data flows, and ethical risks embedded in these emerging platforms.

AI systems require public data and cooperation to function responsibly, yet people won’t share their data unless they already trust the systems collecting and utilizing it. Solving this paradox must be a policy priority for developers and the Canadian government.